共 26 条
- [23] Impact of Original FDA and New ASCO/CAP Guidelines for HER2/neu Evaluation in Breast Cancer: IHC and FISH scores using Manual or Quantitative-Automated Imaging Systems and Different Fixatives JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 604 - 604
- [25] Attainment of extremely high concordance rates between fluorescence in situ hybridization and immunohistochemistry in testing for human epidermal growth factor receptor 2 (HER2) in breast cancer using a normalized scoring system for immunohistochemistry: a four year experience with over 9000 cases CANCER RESEARCH, 2012, 72
- [26] Reassignment of HER2 status for subgroups of breast cancer according to the 2018 updated American Society of Clinical Oncology and College of American Pathologists guidelines: The impact of combined immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) reflex testing in a large national reference laboratory. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)